Nuclear receptors as targets for drug development: Peroxisome proliferator-activated receptor γ in mast cells: Its roles in proliferation and differentiation

Journal of Pharmacological Sciences

Volumn 97, Issue 2, 2005, Pages 190-194

  Maeyama, Kazutaka ^a   Emi, Maiko ^a   Tachibana, Masashi ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Differentiation; Histamine; Mast cell; Peroxisome proliferator activated receptor (PPAR) ; Proliferation

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; CELL NUCLEUS RECEPTOR; INTERLEUKIN 3; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROSTAGLANDIN D2; STEM CELL FACTOR;

BONE MARROW; CELL CULTURE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONFERENCE PAPER; CULTURE MEDIUM; FIBROBLAST; IMMUNE RESPONSE; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE;

EID: 15744404842     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.FMJ04008X6     Document Type: Conference Paper

References (15)

1. Corton JC, Anderson SP, Stauber A. Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators. Annu Rev Pharmacol Toxicol. 2000;40:491-518.
2. Murphy GJ, Holder JC. PPAR-γ agonists: therapeutic role in diabetes, inflammation and cancer. Trends Pharmacol Sci. 2000;21:469-474.
3. Rosen ED, Spiegelman BM. PPARγ: A nuclear regulator of metabolism, differentiation, and cell growth. J Biol Chem. 2001;276:37731-37734.
4. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator activated receptor-γ is a negative regulation of macrophage activation. Nature. 1998;391:79-82.
5. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature. 1998;391:82-86.
6. Metcalfe DD, Baram D, Mekori YA. Mast cells. Physiol Rev. 1997;77:1033-1079.
7. Tkaczyk C, Gilfillan AM. FcεRI-dependent signaling pathway in human mast cells. Clin Immunol. 2001;99:198-210.
8. Takada I, Suzawa M, Kato S. Nuclear receptors as targets for drug development: Crosstalk between peroxisome proliferator-activated receptor γ and cytokines in bone marrow-derived mesenchymal stem cells. J Pharmacol Sci. 2005;97:184-189.
9. Lee SA, Fitzgerald SM, Huang SK, Li C, Chi DS, Milhorn DM, et al. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta. Am J Respir Cell Mol Biol. 2004;31:283-291.
10. Setoguchi K, Misaki Y, Terauchi Y, Yamauchi T, Kawahata K, Kadowaki T, et al. Peroxisome proliferator-activated receptor γ haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis. J Clin Invest. 2001;108:1667-1675.
11. Wright HM, Clish CB, Mikami T, Hauser S, Yanagi K, Hiramatsu R, et al. A synthetic antagonist for the peroxisome proliferator-activated receptor γ inhibits adipocyte differentiation. J Biol Chem. 2000;275:1873-1877.
12. Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, Nakahata T. Peroxisome proliferator-activated receptors are expressed in mouse bone marrow-derived mast cells. FEBS Letters. 2000;467:259-262.
13. Sugiyama H, Nonaka T, Kishimoto T, Komoriya K, Tsuji K, Nakahata T. Peroxisome proliferator-activated receptors are expressed in human cultured mast cells: a possible role of these receptors in negative regulation of mast cell activation. Eur J Immunol. 2000;30:3363-3370.
14. Fujimura Y, Tachibana H, Yamada K. Peroxisome proliferator-activated receptor ligands negatively regulate the expression of the high-affinity IgE receptor FcεRI in human basophilic KU812 cells. Biochem Biophys Res Commun. 2002;297:193-201.
15. Bagga S, Price KS, Lin DA, Friend DS, Austen KF, Boyce JA. Lysophosphatidic acid accelerates the development of human mast cells. Bood. 2004;104:4080-4087.